PIK3CA and neoplasm: In addition, there was a higher rate of PIK3CA mutation in the high-risk subgroup compared with the low-risk subgroup, which could mean that tumor growth in high-risk BRCA cases is promoted through the PI3K–AKT signaling pathway (Xing et al., 2019).